parthenolide and trametinib

parthenolide has been researched along with trametinib in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Czyz, M; Hartman, ML; Nejc, D; Sztiller-Sikorska, M; Talar, B	1

Other Studies

1 other study(ies) available for parthenolide and trametinib

Article	Year
Parthenolide induces MITF-M downregulation and senescence in patient-derived MITF-M(high) melanoma cell populations. Oncotarget, 2016, Feb-23, Volume: 7, Issue:8 Topics: Antineoplastic Agents; Cell Proliferation; Cell Survival; Down-Regulation; Extracellular Signal-Regulated MAP Kinases; Histone Deacetylase 1; Humans; MAP Kinase Signaling System; Melanoma; Microphthalmia-Associated Transcription Factor; Myeloid Cell Leukemia Sequence 1 Protein; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Pyridones; Pyrimidinones; Sesquiterpenes; Transcription Factor RelA; Tumor Cells, Cultured	2016

Article

Year

Parthenolide induces MITF-M downregulation and senescence in patient-derived MITF-M(high) melanoma cell populations.

Oncotarget, 2016, Feb-23, Volume: 7, Issue:8

Topics: Antineoplastic Agents; Cell Proliferation; Cell Survival; Down-Regulation; Extracellular Signal-Regulated MAP Kinases; Histone Deacetylase 1; Humans; MAP Kinase Signaling System; Melanoma; Microphthalmia-Associated Transcription Factor; Myeloid Cell Leukemia Sequence 1 Protein; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Pyridones; Pyrimidinones; Sesquiterpenes; Transcription Factor RelA; Tumor Cells, Cultured

2016